Found 8 matching trials
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
PHASE3The purpose of this study is to demonstrate that SYD985 \[(vic-)trastuzumab...
Location
Southern Cancer Center
Lapatinib in Combination With Vinorelbine
PHASE2This is a randomized, parallel-arm, open-label, multi-centre, Phase II stud...
Location
Novartis Investigative Site
Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer
PHASE1The purpose of the study is to investigate safety and efficiency of the tri...
Location
Onkologie Ravensburg
A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer
PHASE2Evaluating the Efficacy of Lapatinib in Combination With Chemotherapy in Pa...
Location
Sun Yat-sen University Cancer Center
DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs
PHASE3The HER2 status in breast cancer patients may change during the course of t...
Location
University Hospital Ulm
Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment.
PHASE2Despite these initial positive signals in recent statistics, breast cancer ...
Location
Dr. Guillermo Lerzo
Chemotherapeutic Agents in Brain/Breast
N/ARATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Location
Memorial Sloan Kettering
Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine
N/APyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine...
Location
Fudan University Shanghai Cancer Center